To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
Chemotherapy; Targeted therapy; Immunotherapy; Clinical trials for sarcoma and head and neck malignancies
I am a medical oncologist specializing in cancers of the bones and soft tissue (sarcoma) as well as the head and neck. I was drawn to oncology during medical school, where I was struck by the depth and multifaceted nature of the relationships that we develop with our patients. I was privileged to witness the important role we can play in understanding each individual person’s hopes and goals, providing up-to-date and nuanced information and therapies, listening to experiences, and relieving suffering. My time in a laboratory setting has also highlighted for me how our field has truly harnessed the advances in our understanding of molecular pathways to help people live longer and better. As I stated on my application when I decided to be an oncology fellow: to be an oncologist is to truly care about the very big and the very small.
I came to Fox Chase Cancer Center after completing my fellowship at Thomas Jefferson University Hospital. From the moment I came, I was impressed with the dedication, sense of common purpose, and kindness of every person I have met. Now, I am focused on developing clinical trials as well as partnering with the talented scientists here on translational research that can lead to new innovations in treating the patients I see.
2018-2021 - Fellowship, Hematology/Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
2014-2017 - Residency, Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
2005 - 2014 - MD, magna cum laude, and PhD, Microbiology and Immunology, University of Maryland, Baltimore, MD
1999-2003, BA, Biology, cum laude, Harvard University, Cambridge, MA
2018 - Present - American Society of Clinical Oncology
2018 - Present - American Society of Hematology
2013 - Present - American College of Physicians
2010 - 2011 - American Association for Cancer Research
2009 - 2011 - International Society for Interferon and Cytokine Research
Honors & Awards
2016 - Resident Award in Patient Satisfaction, Thomas Jefferson University Hospital
2016 - Professionalism Award, Thomas Jefferson University Hospital
2015 - Professionalism Award, Thomas Jefferson University Hospital
2013 - Elected to Alpha Omega Alpha Society, University of Maryland School of Medicine
2009-2011 - NIH T32 Training Grant, University of Maryland, Baltimore
2009 - Milstein Travel Award, International Society for Interferon and Cytokine Research
2008 - 1st place Rotation Project: Annual Student Presentation, Program in Molecular Microbiology & Immunology, University of Maryland, Baltimore
2005-2008 - University of Maryland, Baltimore: 4.0 average, Honors in Structure and Development, Cell and Molecular Biology, Functional Systems, Host Defenses and Infectious Disease
1999-2003 - Harvard College Academic Scholarship, Harvard University
Sarcoma; Head and neck cancers; Drug development
Laufer MK, van Oosterhout JJ, Thesing PC, Dzinjalamala FK, Hsi T, Beraho L, Graham SM, Taylor TE, Plowe CV. Malaria treatment efficacy among people living with HIV: the role of host and parasite factors. Am J Trop Med Hyg. 2007 Oct;77(4):627-32
Li XL, Ezelle HJ, Hsi TY, Hassel BA. A central role for RNA in the induction and biological activities of type 1 IFNs. WIRES RNA. 2011 Jan/Feb; 2(1): 58-78
Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA. Regulation of Human RNase-L by the miR-29 Family Reveals a Novel Oncogenic Role in Chronic Myelogenous Leukemia. J Interferon Cytokine Res. 2013 Jan;33(1):34-42 (Featured article in this issue)
Lee, TY. The Patient’s Wife. J Gen Int Med. 2017 Oct 30 (Web Only: Medical Humanities)
Lee, TY, Martinez-Outschoorn UE, Schilder RJ, Kim CH, Richard SD, Rosenblum NG, Johnson JM. Metformin as a Therapeutic Target in Endometrial Cancers. Front Oncol. 2018 Aug 28; 8:341
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.